1. Loneliness multiplies by five the chances of developing depression

    A study published in the Journal of affective disorders and led by Dr. Joan Domènech, researcher at the Institut de Recerca Sant Joan de Déu (IRSJD), determines that the probability that a person living in a situation of loneliness will develop depression is five times greater than one that does not have this kind of feeling.

  2. Measuring antibodies in saliva is a useful and easy strategy to detect SARS-CoV-2 infections

    A study, published in BMC Medicine, performed through the Kids Corona platform from Sant Joan de Déu in collaboration with ISGlobal, shows that measuring antibodies in saliva is a useful and easy strategy to detect SARS-CoV-2 infections.

  3. Two subtypes of retinoblastoma identified

    Researchers from the Institut de Recerca Sant Joan de Déu have collaborated in a study, published in Nature Communications, which has identified two subtypes of molecular retinoblastoma with different genomic, clinical and pathological features.

  4. Brown adipose tissue activity is higher in girls during the first year of life

    A team led by Dr Lourdes Ibáñez and Dr Francesc Villarroya, IRSJD researchers, publishes the first study that shows the very early appearance of differences in the activity of the brown adipose tissue between girls and boys

  5. Researchers discover new phenotypic characteristics in inherited disorders of neurotransmitter metabolism

    The study co-led by Dr Àngels Garcia-Cazorla, Institut de Recerca Sant Joan de Déu (IRSJD), has studied more than 270 patients with ultra-rare neuro-metabolic diseases to describe and evaluate their initial clinical and biochemical characteristics improve their diagnosis.

  6. Detecting long QT syndrome early could help reduce the impact of sudden infant death

    A team led by Dra. Georgia Sarquella (IRSJD) and Drs. Ramon Brugada and Oscar Campuzano (IDIBGI) provide new diagnostic measures to prevent sudden infant death from long QT syndrome.

  7. Retaining talent and fostering public-private partnerships, some of the challenges that is facing the HealthTech sector

    Xartec Salut has opened the debate on the main challenges of the Catalan ecosystem to become an international reference in the field of health technologies.

  8. Dr. Lourdes Ibañez coordinates the European SPIOMET4HEALTH project: a new treatment for polycystic ovary syndrome in adolescents and young women

    Dr. Lourdes Ibañez, from the Institut de Recerca Sant Joan de Déu, coordinates the new European SPIOMET4HEALTH will test the efficacy of this new treatment for Polycystic Ovary Syndrome (PCOS) in adolescent girls and young adult women, in a multi-centric phase II clinical trial.

  9. Survival rate of high-risk neuroblastoma patients treated with next-generation immunotherapy at SJD Barcelona Children's Hospital

    Researchers of SJD Barcelona Children's Hospital and of Institut de Recerca Sant Joan de Déu (IRSJD) have published the results of treatment with the humanised anti-GD2 antibody Naxitamab (DanyelzaR) combined with granulocyte-macrophage colony-stimulating factor (GM-CSF; LeukineR) in high-risk neuroblastoma patients.